학술논문

A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the "on-demand" scheme of administration at French autologous hematopoietic stem cell transplant programs
Document Type
Article
Source
In: Transfusion. (Transfusion, 1 September 2015, 55(9):2149-2157)
Subject
Language
English
ISSN
15372995
00411132